Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy
Cell Proliferation · 2025-03 · 58 (3)
DOI: 10.1111/cpr.13779 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2024-12-03. Written by Yiming Zhang and 9 co-authors. Institution: Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, China. Major MEDLINE topics: Ferroptosis, Osteoarthritis. Cited 46 times so far (Crossref); 157 references. The full text is freely available (open access, CC BY 4.0). Funded by: Chinese Postdoctoral Research Program, the Major Basic Research Project of the Natural Science Foundation of Shandong Province, the Taishan Scholars Program of Shandong Province.
Abstract (original language)
Osteoarthritis (OA) is a chronic, degenerative joint disease primarily characterised by damage to the articular cartilage, synovitis and persistent pain, and has become one of the most common diseases worldwide. In OA cartilage, various forms of cell death have been identified, including apoptosis, necroptosis and autophagic cell death. Ever‐growing observations indicate that ferroptosis, a newly‐discovered iron‐dependent form of regulated cell death, is detrimental to OA occurrence and progression. In this review, we first analyse the pathogenetic mechanisms of OA by which iron overload, inflammatory response and mechanical stress contribute to ferroptosis. We then discuss how ferroptosis exacerbates OA progression, focusing on its impact on chondrocyte viability, synoviocyte populations and extracellular matrix integrity. Finally, we highlight several potential therapeutic strategies targeting ferroptosis that could be explored for the treatment of OA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, China.
- Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Hematology, Rizhao People's Hospital, Rizhao, China.
- Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- International Joint Laboratory of Medicinal Food R&D and Health Products Creation/Biological Engineering Technology Innovation Center of Shandong Province, Heze Branch of Qilu University of Technology (Shandong Academy…
- Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases; Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Chinese Academy of Medical Sciences…
ORCID profiles: Xiao Hu, Zheng Wang
Funding
- Chinese Postdoctoral Research Program
- the Major Basic Research Project of the Natural Science Foundation of Shandong Province
- the Taishan Scholars Program of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Industry Integration Innovation Pilot Project from Qilu University of Technology (Shandong Academy of Sciences)
- Shandong Academy of Sciences
Cite
APA
Zhang, Y., Li, J., Liu, J., Gao, Y., Li, K., Zhao, X., Liu, Y., Wang, D., Hu, X., & Wang, Z. (2025). Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy. Cell Proliferation, 58(3). https://doi.org/10.1111/cpr.13779
Vancouver
Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X, et al. Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy. Cell Proliferation. 2025;58(3). doi:10.1111/cpr.13779
BibTeX
@article{Zhang2025,
author = {Zhang, Yiming and Li, Jing and Liu, Jiane and Gao, Yan and Li, Kehan and Zhao, Xinyu and Liu, Yufeng and Wang, Daijie and Hu, Xiao and Wang, Zheng},
title = {Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {3},
doi = {10.1111/cpr.13779}
}
EUVIMED